Status:

COMPLETED

Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity

Lead Sponsor:

St. Luke's-Roosevelt Hospital Center

Conditions:

Pleural Metastases

Breast Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Cancers that have spread to the inner lining of the chest are classified as Stage IV and bear a poor prognosis. Surgery is rarely an option, with palliative chemotherapy and/or radiation therapy the o...

Eligibility Criteria

Inclusion

  • Adults aged 18-75 years
  • Radiographic evidence of pleural dissemination with histologically or cytologically confirmed diagnosis.
  • Primary source control (breast, ovarian, uterine, colon, renal cell, thymic cancer)
  • Adequate liver and renal function defined as a bilirubin of \< 2.0 mg/dl, albumin \> 3.0g/dl, and a creatinine of \< 1.5 mg/dl, respectively.
  • Absolute neutrophil count (ANC) of ≥1,500/mm3 and a platelet count ≥100,000/mm3.
  • A Karnofsky Performance Status score of ≥60

Exclusion

  • Patients without satisfactory oncological control of their primary cancer.
  • Radiographic evidence of abdominal, pelvic, or intracranial metastatic disease.
  • Chemotherapy and/or radiotherapy must have been completed at least one month prior to entry in the study. Patients may not receive concurrent chemotherapy, immunotherapy, radiotherapy, or any investigational drugs while participating in this study.
  • Significant active medical disease including, but not limited to:
  • Cardiac disease, including: congestive heart failure or angina pectoris; recent (within 1 year) history of a myocardial infarction; uncontrolled hypertension; arrhythmias.
  • Active infections
  • Uncontrolled diabetes mellitus
  • Chronic renal insufficiency
  • HIV/AIDS - routine HIV testing will not be performed, but patients known to be HIV positive will be excluded.
  • Pregnant or lactating women.
  • Allergy to intravenous contrast

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT01163552

Start Date

June 1 2010

End Date

May 1 2014

Last Update

June 13 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Luke's-Roosevelt Hospital Center

New York, New York, United States, 10019